A surgeon, a product director and a preclinical study director bump into each other at the Omni Shoreham lobby…

Well, not exactly, but that’s the way the annual CRT conference feels. Like a well designed meeting hub, the event generates “productive collisions” that foster innovation and learning throughout the cardiovascular research technologies ecosystem.

Why we always look forward to CRT

All of the product developers, the captains and innovators of the industry, are present including key decision makers on scientific programs and FDA representatives who provide guidance to the individuals  actually doing the work. This is invaluable to our preclinical sponsors, both existing and prospective. All are highly focused on cardiovascular research: discussing their needs, advancements and getting their projects primed for the next phase whatever that might be: design, preclinical, surgical training, advanced imaging or clinical research. CRT’s intense focus on real scientific, translational research that spans the continuum of new cardiovascular innovation gets our scientific brains buzzing.

Originally founded as a cardiovascular research institute, T3 Labs and its staff has over a decade long track-record in preclinical cardiovascular studies including interventional cardiology, valves and structural heart devices. Our study directors aren’t just pushing paper. They are trained engineers and scientists with a passion for impacting healthcare now and helping Sponsor return share/stakeholder.

From concept to cure, T3 Labs knows preclinical research. Leading cardiologists do their preclinical work at T3 Labs. St. Jude Medical and Surefire Medical among dozens of other industry leading medtech innovators rely on T3 for preclinical studies as well. And our imaging capabilities are second-to-none. Other start-up companies and global leaders in the science of heart valves and hemodynamic monitoring, engaged T3 Labs for cardiovascular testing and training and product launch.

Who’s going to CRT 2016?

Who wants to connect and talk valves, structural heart and endovascular research and development? Aside from the high value interactions that CRT 2016 engenders thanks to its content, design and variety of attendees, here are a few of the top items on the conference agenda we can’t wait to consume.

  • Saturday, February 20
    • CRT Valve – Imaging – 12:30-3:15 – Blue Room
  • Sunday, February 21
    • CRT Valve – Mitral – 6:30 a.m. – 2:30 p.m. – Blue Room
    • CRT Valve – Embolic Protection Devices – 3:50 – 5:00 p.m. – Blue Room
  • Monday, February 22
    • CRT Valve – Aortic – 6:30 a.m. – 12:00 p.m. – Regency Room
    • CRT Endovascular – Critical Limb Ischemia – 9:00 a.m. – 5:30 p.m. – Palladian
    • CRT Valve & Structure with FDA – 12:50 p.m. – 5:00 p.m. – Blue Room
  • Tuesday, February 23
    • CRT Valve – Structural Innovation – 8:00 a.m. – 11:30 a.m. – Diplomat
    • CRT Endovascular & AAA – 8:00 a.m. – 2:45 pm. – Palladian
    • FDA Town Hall – 8:15 a.m. – 4:00 p.m. – Blue Room

Find the entire conference advance program here.

Connect with us at CRT 2016! 

Email T3 Labs Executive Director Andrew Stevenson (that’s me) at andrew.stevenson@emoryhealthcare.org, Deepal Panchal, Program Director for Testing at deepal.panchal@emoryhealthcare.org, or Program Manager and echocardiography expert Michael Sweet at michael.sweet@emoryhealthcare.org